Skip to main content

Table 2 Concentrations of the cholesterol subfractions measured by Lipoprint in MS patients and controls. Data are expressed as mean ± SD, in case of non-parametric distribution as median (25th - 75th percentile)

From: Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?

 MS (n = 19)Controls (n = 19)
VLDL (mmol/l)0.757 ± 0.3280.595 (0.524–0.847)
IDL-A (mmol/l)0.218 ± 0.1050.216 ± 0.086
IDL-B (mmol/l)0.259 (0.207–0.310)0.233 (0.181–0.284)
IDL-C (mmol/l)0.885 ± 0.2430.834 ± 0.198
LDL1 (mmol/l)0.361 ± 0.2730.404 ± 0.230
LDL2 (mmol/l)0.207 (0.000–0.259)0.200 ± 0.217
LDL3–7 (mmol/l)0.000 (0.000–0.052)0.000 (0.000–0.039)
Large HDL (mmol/l)0.763 (0.595–0.957)0.709 ± 0.271
Intermediate HDL (mmol/l)0.646 (0.543–0.802)0.621 ± 0.113
Small HDL (mmol/l)0.111 ± 0.0850.090 ± 0.072
Total cholesterol (mmol/l)4.54 ± 0.954.07 ± 0.73